Photo of Helen Hanby, Biogen, Marco Buzzi, Bank of America Merrill Lynch and Steve Green, Biogen.
This card programme is an excellent example of best practice in the roll-out and ongoing management of a global scheme. Essential to its success is the fact that the roll-out was ‘owned’ by the treasury team.
Helen Hanby
Associate Director, International Treasury
Biogen is one of the world’s oldest independent biotechnology companies. It specialises in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic and autoimmune diseases to patients worldwide.
in partnership with
Rapid roll-out of global card solution
The challenge
The firm’s card programme was originally set up with the US in mind. As the company had grown internationally, each country had responded to the needs of its travelling staff by developing their own, local card programme. The result was a lack of standardisation across the group, with no or inconsistent data from multiple sources being fed into its Oracle Enterprise Resource Planning (ERP) system.
The solution
Having worked with Bank of America Merrill Lynch (BofAML) on the firm’s global cash management requirements, Biogen asked the bank to tender for the provision of a global card solution.
With the acceptance of BofAML’s proposal, the project, which was being driven by treasury, rather than procurement, could proceed via established links into the bank. This allowed for tight integration of the card data with the company’s expense management platform and with its enterprise resource planning (ERP) system. The result was a rapid roll-out.
The programme began in the UK, but was rapidly extended to over 25 European countries. Such was its success that it was subsequently adopted by the US, replacing a long-standing legacy card offering, resulting in a truly global programme.
Today, all the company’s T&E is handled through a single card programme, with travelling staff using company Mastercards provided through BofAML. Additionally, this year, lodge cards have been put in place for Biogen’s global travel provider to pay flight costs, which are also contributing to the company’s rebate.